InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-21 · accession 0001477449-25-000065 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-23 2025-05-21 TDOC SHEDLARZ DAVID L Dir M - OptEx — +17.5K 32.3K +118% —
D 2025-05-23 2025-05-22 TDOC SHEDLARZ DAVID L Dir A - Grant $0.00 +29.0K 29.0K New $0
D 2025-05-23 2025-05-21 TDOC SHEDLARZ DAVID L Dir M - OptEx $0.00 -17.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-21 M A 17,467 — 32,280 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2025-05-22 A A 28,986 $0.00 28,986 D — · — to — 28,986 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F4) The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders.
3 Derivative Restricted Stock Units 2025-05-21 M D 17,467 $0.00 0 D — · — to — 17,467 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F2) On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025.